How Do Regulatory Bodies Ensure Safety Post-Approval?
After a drug is approved, regulatory bodies continue to monitor its safety through post-market surveillance. This involves tracking adverse events and side effects reported by healthcare providers and patients. If significant safety issues arise, regulatory bodies can issue warnings, mandate label changes, or even withdraw the drug from the market. This ongoing vigilance helps protect patients from unforeseen risks.
